21st International Congress » Other

Date: Thursday, June 8, 2017

Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Meeting: 21st International Congress

1:15pm-2:45pm: 3D image as a complimentary assist in patients with Parkinson’s disease

D. Khodjieva, N. Mansurova, N. Khaydarov (Bukhara, Uzbekistan)

1:15pm-2:45pm: A combined cognitive and motor exercise program for people with Parkinson’s disease and Freezing of gait; a pilot study.

L. King, K. Smulders, M. Mancini, J. Lapidus, P. Carlson-Kuhta, B. Fling, J. Nutt, F. Horak (Portland, OR, USA)

1:15pm-2:45pm: Availability of anti-Parkinsonian drugs in Thailand

K. Sakdisornchai, R. Bhidayasiri, O. Jitkritsadakul, p. panyakaew, J. Sringean (Bangkok, Thailand)

1:15pm-2:45pm: Baseline predictors for clinical progression after 48 month follow-up in early Parkinson’s disease from the DeNoPa cohort

B. Mollenhauer, J. Zimmermann, F. Sixel-Döring, N. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, C. Trenkwalder (Kassel, Germany)

1:15pm-2:45pm: Characterization of Pisa syndrome in Parkinson’s disease.

T. Clark, J. Nutt, F. Horak, M. Mancini, M. Jurado, T. Hullar (Portland, OR, USA)

1:15pm-2:45pm: Characterizing task-based acoustic variations of vowels in Parkinson’s disease: Preliminary data

C. Kuo (Harrisonburg, VA, USA)

1:15pm-2:45pm: Cinnamomum verum on Learning and Memory in Wistar Albino Rats

N. AHMED, D. AGRAWAL, A. CHUGHTAI (ALIGARH, India)

1:15pm-2:45pm: Clinical and electrophysiological features of seven patients with moving toes syndrome: Is it a type of spinal segmental myoclonus?

G. Kiziltan, H. Kurucu, C. Yalcinkaya, A. Gunduz, M. E. Kiziltan (Istanbul, Turkey)

1:15pm-2:45pm: Clinical Criteria for Subtyping Parkinson’s Disease: Differences in imaging and CSF biomarkers and longitudinal progression

S.-M. Fereshtehnejad, Y. Zeighami, A. Dagher, R. Postuma (Montreal, QC, Canada)

1:15pm-2:45pm: CSF, plasma and saliva alpha-Synuclein in moderately advanced Parkinson’s disease cohort: the BioFIND study

R. Alcalay, A. Amara, P. Taylor, H. Andrews, J. Goldman, T. Xi, P. Tuite, C. Henchcliffe, P. Hogarth, S. Frank, M.-H. Saint Hilaire, A. Naito, M. Frasier, V. Arnedo, A. Reimer, M. Sutherland, C. Swanson-Fischer, K. Gwinn, U. Kang (NYC, NY, USA)

1:15pm-2:45pm: Death in patients with Parkinson’s disease – an observational study

R. Mappilakkandy, A. Pieris, D. Miodrag, A. Chunduri (Northampton, United Kingdom)

1:15pm-2:45pm: Developing a guide to facilitate involving people with Parkinson’s and their carers in service improvement

N. Shaw, V. Evans, J. Rideout, C. Carroll (Plymouth, United Kingdom)

1:15pm-2:45pm: Development of a Clinical Outcomes Assessment (COA) in Pantothenate-Kinase Associated Neurodegeneration (PKAN): Item Generation and Clinimetric Properties

R. Marshall, A. Collins, M. Escolar, H.A. Jinnah, T. Klopstock, M. Kruer, A. Videnovic, A. Robichaux-Viehoever, L. Swett, D. Revicki, R. Bender, W. Lenderking (Cambridge, MA, USA)

1:15pm-2:45pm: Development of utility to evaluate a symptomatic diary of motor fluctuations of Parkinson’s disease (PD) using a smartphone application.

H. Ohtsubo, H. Iwaki, H. Yabe, M. Nagai, M. Nomoto (Matsuyama Ehime, Japan)

1:15pm-2:45pm: Differences between Hemifacial spasm with or without neurovascular conflict. Therapeutic implications with botulinum toxin type A.

J.S. Bestoso, L. Ciancaglini, C. Stefani, C. Azcona, M.L. Contartese, A. Pappolla, J.I. Rojas, D. Bauso (Buenos Aires, Argentina)

1:15pm-2:45pm: Disease modeling for Perry syndrome using patient induced pluripotent stem cells

T. Mishima, T. Ishikawa, K. Imamura, T. Kondo, Y. Koshiba, R. Takahashi, J. Takahashi, A. Watanabe, N. Fujii, Y. Tsuboi, H. Inoue (Fukuoka, Japan)

1:15pm-2:45pm: Effect of object size and obstacle avoidance on of Reach-to-Grasp Actions in Individuals with Parkinson’s disease

S. Khacharoen, J. Tretriluxana, P. Srivanitchapoom, A. Pisarnpong, T. Chandharohit (Nakhon Pathom, Thailand)

1:15pm-2:45pm: Elevated GM3 Plasma Concentration in Idiopathic Parkinson’s Disease: a Lipidomics Analysis

R. Alcalay, R. Chan, C. Liong, A. Perotte, B. Zhou, E. Shorr, K. Marder, U. Kang, C. Waters, O. Levy, Y. Xu, H. Shim, I. Pe'er, G. Di Paolo (New York, NY, USA)

1:15pm-2:45pm: End of Life Care in Parkinson’s Disease

S. Mole, S. Jackson (Exeter, United Kingdom)

1:15pm-2:45pm: Epidemiological profile and challenges of a reference public center for the treatment of neurological conditions using botulinum toxin type A: experience of a North-eastern center in Brazil.

R. Prado, W. Cunha, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)

1:15pm-2:45pm: Epilepsy and Cranial nerve affection in a Patient with Wilson’s disease and Intracranial developmental venous anomaly; A Case Report

W. Ezzat, A. Mohamed (cairo, Egypt)

1:15pm-2:45pm: Evaluating the Experience of Diagnosis in Parkinson’s Disease

A. Robinson, E. Pearson, F. Murphy, J. Davis, C. Carroll (Plymouth, United Kingdom)

1:15pm-2:45pm: Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?

T. Drori, J. Chapman, M. Lidar, P. Langevitz, Y. Shoenfeld, O. Cohen (Ramat-Gan, Israel)

1:15pm-2:45pm: Falls characteristics of male and female patients with Parkinson’s disease (PD)

G. Alg, A. Chatterjee, F. Zahir (Reading, United Kingdom)

1:15pm-2:45pm: Falls in Parkinson’s disease are related to delayed recovery time after unexpected external perturbations

V. Beretta, F. Barbieri, D. Orcioli-Silva, P. Santos, M. Pereira, R. Vitório, L. Gobbi (Rio Claro, Brazil)

1:15pm-2:45pm: Gait and Balance Impairment After Methanol Intoxication

K. Peterová, H. Brožová, J. Klempíř, I. Lišková, S. Zakharov, O. Bezdíček, M. Vaněčková, Z. Seidl, E. Růžička (Prague, Czech Republic)

1:15pm-2:45pm: Gait asymmetry and asymmetry index in a sample of patients with PD and control group in Cali – Colombia.

B. Munoz, A. Enriquez-Marulanda, J. Orozco (Cali, Colombia)

1:15pm-2:45pm: High intensity interval training improves psychomotor function in individuals with Parkinson’s disease

J. Marusiak, B. Fisher, A. Jaskólska, K. Słotwinski, S. Budrewicz, M. Koszewicz, K. Kisiel-Sajewicz, A. Jaskólski (Wroclaw, Poland)

1:15pm-2:45pm: Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study

M. Amarandei (Bucharest, Romania)

1:15pm-2:45pm: In-patient Parkinson courses and caregiver burden

K. Martikainen, S. Kinos, R. Marttila (Turku, Finland)

1:15pm-2:45pm: Incorporating Specialist Independent Prescribing Pharmacist (SIPP) sessions into the Movement Disorder Service

D. Fletcher, E. Thomas, B. Mohamed (Cardiff, United Kingdom)

1:15pm-2:45pm: Inpatient care for stiff person syndrome in the United States: A nationwide readmission study

J. Crispo, D. Thibault, Y. Fortin, A. Willis (Sudbury, ON, Canada)

1:15pm-2:45pm: Management of fragility fractures in Parkinson’s Disease (PD)

G. Alg, A. Chatterjee (Reading, United Kingdom)

1:15pm-2:45pm: Motor Heterogeneity in Parkinson’s Disease: A Bayesian Perspective

A. Johnson, A. Loftus, N. Gasson, B. Lawrence, M. Thomas, R. Bucks (Perth, Australia)

1:15pm-2:45pm: Movement Disorders in Demyelinating Diseases: a retrospective review from a tertiary academic center.

G. Suarez-Cedeno, M. Raja (Houston, TX, USA)

1:15pm-2:45pm: Multidisciplinary intensive outpatient rehabilitation program for patients with advanced Parkinson’s disease: feasibility and primary proof of concept

T. Gurevich, T. GAIL, n. choen, o. KADURRI, L. SHTRAIFLER, I. BADICHI, N. RIPS CASSERI (tel aviv, Israel)

1:15pm-2:45pm: Neural correlates of movement sequence kinematics in substantia nigra dopaminergic cells

M. Mendonça, J. Alves Silva, L. Hernandez, J. Obeso, R. Costa (Lisboa, Portugal)

1:15pm-2:45pm: Neuroprotective propensity of PTUPB, a dual inhibitor of sEH and COX-2 against rotenone induced neurotoxicity in cell line and Drosophila model of Parkinson disease

N. Lakkappa, P. Thaggikuppe Krishnamurthy, P.D. Mirazkar, N. Lakkappa, P. Krishnamurthy, P.M.D., M.M. Srinivas Bharath, B. Hammock, S.H. Hwang (Udhagamandalam, India)

1:15pm-2:45pm: New method to evaluate new motor skill learning

A.P. Quixadá, V. Sotero, J.-F. Daneault, G. Diaz, Â. Torres, J.P. Vieira, M. Fonseca, P. Bonato, N. Peña, J.G. Miranda (Salvador, Brazil)

1:15pm-2:45pm: NS-PARK/FCRIN network, the French Clinical Research Network for Parkinson’s disease and Movement Disorders

E. Dellapina, V. Chaigneau, F. Durif, J.-C. Corvol, O. Rascol, F. NS-PARK/FCRIN network (Toulouse, France)

1:15pm-2:45pm: Ocular Motor Disorders Among Filipino “LUBAG” or X-Linked Dystonia Parkinsonism (XDP) Patients

M. Macas, E.C. Rossi, S. Abantas-Diamla, A. Punzalan-Sotelo, E. Palisoc, C. Go (Manila, Philippines)

1:15pm-2:45pm: Optimization and evaluation of whole body MRI sequences for patients with deep brain stimulators

C. Drews, S. Wolff, L. Lunden, O. Jansen (Kiel, Germany)

1:15pm-2:45pm: Oscillatory Activity in the Nucleus Basalis of Meynert

M. Nazmuddin, D. Oterdoom, J. van Zijl, A. Kampman, J. van Dijk, G. Drost, T. van Laar, M. Beudel (Groningen, Netherlands)

1:15pm-2:45pm: Patients affected by functional motor symptoms are not liars: an experimental deception study with the Guilty Knowledge Task

B. Demartini, R. Ferrucci, D. Goeta, F. Ruggiero, A. Priori, O. Gambini (Milano, Italy)

1:15pm-2:45pm: Physical Activity in Early Parkinson Disease

S. Mantri, M. Fullard, J. Duda, J. Morley (Philadelphia, PA, USA)

1:15pm-2:45pm: Polyneuropathy in patients with Parkinson’s disease from southern Spain treatment with levodopa/carbidopa intestinal gel infusión

F. Carrillo, S. Jesus, L. Vargas, M. Bernal, M.T. Caceres, A.D. Adarmes, M. Carballo, P. Mir (Seville, Spain)

1:15pm-2:45pm: Pregnancy and Parkinson’s disease: A review and update

M. Seier, A. Hiller (Portland, OR, USA)

1:15pm-2:45pm: Prevalence of Babinski-2 sign in Hemifacial Spasm Patients

O. Dogu, H. Kalegasi (Mersin, Turkey)

1:15pm-2:45pm: Self Perception of Dysphagia in Parkinson Disease

A. Silbergleit, C. Sidiropoulos, R. Konnai, L. Schultz, A. Kitowski, P. LeWitt (West Bloomfield, MI, USA)

1:15pm-2:45pm: Some clincal features of movement disorders after cerebral anoxia.

B. Tserensodnom (Ulaanbaatar, Mongolia)

1:15pm-2:45pm: Stiff-limb syndrome with cerebellar features and atypical EMG findings responds to IVIG

S. Rametta, G. Robinson, N. Hellmers, N. Jacoby, H. Sarva (Brooklyn, NY, USA)

1:15pm-2:45pm: The combination of clinical scales and walking measures to predict falls in Parkinson’s disease: Does the length of the prospective follow-up period matter?

R. Vitório, R. Moraes, A. Baptista, E. Lirani-Silva, L. Simieli, D. Orcioli-Silva, F. Barbieri, L. Gobbi (Rio Claro, Brazil)

1:15pm-2:45pm: The effects of wearing usual indoor and outdoor footwear on balance and gait performance in people with Parkinson’s disease using clinical tests and instrumented movement analysis.

D. Kunkel, M. Burnett, L. Mamode, R. Pickering, C. Bowen, D. Bader, J. Robison, M. Donovan-Hall, M. Cole, A. Ashburn (Southampton, United Kingdom)

1:15pm-2:45pm: The management of Parkinson’s disease in the Middle East countries: the MDS-middle east task force survey

H. Khalil, Z. Aldaajani, S. Baudry, M. Abualmelh, T. Mohammad, M. Salari, M. Bhatt, S. Tabbal, N.A. Syed, B. Jeon, C. Goetz, J.A. Bajwa (Irbid, Jordan)

1:15pm-2:45pm: The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis

J.R. Perez-Sanchez, B. DeLaCasa-Fages, A. Contreras, J.M. Velázquez, A. Muñoz-González, F. Grandas (Madrid, Spain)

1:15pm-2:45pm: The Use of Atypical Antipsychotics in Depression and Anxiety may Unmask Parkinson’s Disease: A Retrospective Chart Review

K. Amodeo, R. Schneider, I. Richard (Rochester, NY, USA)

1:15pm-2:45pm: Treatment of Functional Neurological Disorders: Towards Expert Consensus Led Guidelines for the American Neuropsychiatric Association Committee for Research

O. Ghaffar, M. Modirrousta, C. LaFrance, N. Williams, R. Shura, S. Ducharme, V. Voon (Whitby, ON, Canada)

1:15pm-2:45pm: Validation of the MDS Research Criteria for Prodromal Parkinson’s Disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort

S.-M. Fereshtehnejad, J. Montplaisir, A. Pelletier, J.-F. Gagnon, D. Berg, R. Postuma (Montreal, QC, Canada)

1:15pm-2:45pm: Vascular hemiballismus due to a lentiform nucleus infarct

D. Gams Massi, J. Nyassinde, K. Toure, N.S. Diagne, M. Ndiaye, A.G. Diop, M.M. Ndiaye (Dakar, Senegal)

« View all sessions from the 21st International Congress.